A case of esophageal cancer successfully performed early response evaluation for preoperative chemotherapy by FDG-PET

Japanese Journal of Gastroenterology

Volumn 105, Issue 8, 2008, Pages 1193-1199

  Isa, Tsutomu ^c   Kaneshiro, Takao ^c   Yamamoto, Hirofumi ^c   Nakachi, Atsushi ^c   Teruya, Tsuyoshi ^c   Shiroma, Hiroshi ^a   Arakaki, Kyouko ^a   Nishimaki, Tadashi ^b  

^a Tomishiro Central Hospital   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE; FLUOROURACIL; ANTINEOPLASTIC AGENT; FP PROTOCOL; TEGAFUR; URACIL;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; CERVICAL LYMPH NODE; CLINICAL FEATURE; DRUG RESPONSE; DRUG UPTAKE; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE TREATMENT; ADJUVANT CHEMOTHERAPY; CANCER INVASION; CANCER STAGING; ESOPHAGUS TUMOR; FATALITY; LYMPHADENECTOMY; METASTASIS; MIDDLE AGED; PATHOLOGY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FATAL OUTCOME; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TEGAFUR; URACIL;

EID: 53049093965     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Nishimaki T, Suzuki T, Suzuki S, et al : Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg 186 ; 306-312 : 1998 (Pubitemid 28124435)
2. Kok TC, van Lanschot J, Siersema PD, et al : Neoadjuvant chemotherapy in operable esophageal squamous cell cancer : final report of a phase III multicenter randomized controlled trial. Proc Am Soc Clin Oncol 16 ; 277a : 1997
3. Clark P : Surgical resection with or without preoperative chemotherapy in oesophageal cancer : an update analysis of a randomised controlled trial conducted by the UK Medical Research Council Upper GI Tract Cancer Group. Proc Am Soc Clin Oncol 20 ; 126a : 2001
4. Kelsen DP, Ginsberg R, Pajak TF, et al : Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 ; 1979-1984 : 1998
5. Law S, Fok M, Chow S, et al : Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus : a prospective randomized trial. J Thorac Cardiovasc Surg 114 ; 210-217 : 1997 (Pubitemid 27364211)
6. Ott K, Weber W, Siewert JR : The importance of PET in the diagnosis and response evaluation of esophageal cancer. Dis Esophagus 19 ; 433-442 : 2006 (Pubitemid 44644678)
7. Weber WA, Ott K, Becker K, et al : Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19 ; 3058-3065 : 2001 (Pubitemid 32565444)
8. Ott K, Weber WA, Lordick F, et al : Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J Clin Oncol 24 ; 4692-4698 : 2006
9. Wieder HA, Brucher BL, Zimmermann F, et al : Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22 ; 900-908 : 2004
10. Lordick F, Ott K, Krause BJ, et al : PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction : the MUNICON phase II trial. Lancet Oncol 8 ; 797-805 : 2007